Determinants of Antiretroviral Therapy Initiation and Treatment Outcomes for People Living With HIV in Vietnam

REFERENCES

• Community Research Initiative of New England. New study to ask “When to start HIV treatment.” 2008. http://www.crine.org/templates/cri/pdfs/ACCESSSpringSum-mer08.pdf.
   Google Scholar
• Ministry of Health, ed. Achievements in HIV/AIDS Prevention and Treatment Campaign in 2010 and Plan for 2011. Hanoi: Vietnam Administration for HIV/AIDS Control; 2010.
   Google Scholar
• van Griensven J, Thai S. Predictors of immune recovery and the association with late mortality while on antiretro-viral treatment in Cambodia. Trans Royal Soc Trop Med Hygiene. 2011; 105(12): 694–703.
   PubMed Web of Science ®Google Scholar
• Cascade Collaboration. Changes in the uptake of antiret-roviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE. HIV Med. 2000; 1(4): 224–231.
   PubMedGoogle Scholar
• Amuron B, Levin J, Birunghi J, et al. Mortality in an antiret-roviral therapy programme in Jinja, south-east Uganda: a prospective study. AIDS Res Ther 2011; 8(1): 39.
   PubMed Web of Science ®Google Scholar
• Ford N, Kranzer K, Hilderbrand K, et al. Early initiation of antiretroviral therapy and associated reduction in mortality, morbidity and defaulting in a nurse-managed, community cohort in Lesotho. AIDS. 2010; 24(17): 2645–2650.
   PubMed Web of Science ®Google Scholar
• Lawn SD, Myer L, Harling G, et al. Determinants of mortal-ity and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evalua-tion. Clin Infect Dis. 2006; 43(6): 770–776.
   PubMed Web of Science ®Google Scholar
• Zolopa AR, Andersen J, Powderly W, et al. Early antiret-roviral therapy reduces AIDS progression/death in indi-viduals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE 2009; 4(5): e5575.
   PubMed Web of Science ®Google Scholar
• Sabin CA, Smith CJ, Gumley H, et al. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS. 2004; 18(16): 2145–2151.
   PubMed Web of Science ®Google Scholar
• Wen Y, et al. Some patient-related factors associated with late access to ART in China's free ART program. AIDS Care. 2011;23(10): 1226–1235.
   PubMed Web of Science ®Google Scholar
• Stöhr W, Dunn DT, Porter K, et al. CD4 cell count and initia-tion of antiretroviral therapy: trends in seven UK centres, 1997–2003. HIV Med. 2007; 8(3): 135–141.
   PubMed Web of Science ®Google Scholar
• Wolbers M, Bucher HC, Furrer H, et al. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Med. 2008; 9(6): 397–405.
   PubMed Web of Science ®Google Scholar
• UNAIDS. 2009 AIDS Epidemic Update. http: //www.unaids.org/en/media/unaids/contentassets/dataim-port/pub/report/2009/jc1700_epi_update_2009_en.pdf. Accessed November 26,2012.
   Google Scholar
• Ministry of Health, ed. Procedures of HIV/AIDS treatment by ARV. 2006. Circular 2051/Decision_Ministry of Health.
   Google Scholar
• Nhan TD. Preliminary of the national evaluation of clinical and immunological response to ARV of adult patients in Vietnam. Presented at: National HIV/AIDS Conference, Vietnamese Administration for HIV/AIDS Control, Decem-ber 15, 2010; Hanoi.
   Google Scholar
• Vietnam Administration for HIV/AIDS Control. The national HIV/AIDS epidemiology in the first three months in 2011. In: VAAC, ed. Vietnam Administration for HIV/AIDS Control Report. Hanoi: Ministry of Health: 2011.
   Google Scholar
• World Health Organization. WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immuno-logical Classification of HIV-Related Disease in Adults and Children. Geneva: WHO; 2007.
   Google Scholar
• Kitahata MM, Gange SJ, Abraham AG, et al. Early versus deferred antiretroviral therapy for HIV. New Engl J Med. 2009; 361(8): 822–824.
   Google Scholar
• Chiappini E, Galli L, Tovo P. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection. AIDS. 2006; 20(2): 207–215.
   PubMed Web of Science ®Google Scholar
• Vietnam Administration for HIV/AIDS Control. Viet-nam-2010 Country Progress Report. Hanoi: Hanoi Medical Publishing House; 2010.
   Google Scholar
• Pharris A, Chuc NT, Tishelman C, et al. Expanding HIV testing efforts in concentrated epidemic settings: a popu-lation-based survey from rural Vietnam. PLoS ONE. 2011; 6(1): e16017.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Guidance on provider-initiated HIV testing and counselling in health facilities. 2007. http: //www.who.int/hiv/pub/vct/pitc/en/index.html. Accessed June 2011.
   Google Scholar
• Dalel S, Lee CW, Farirai T, et al. Provider-initiated HIV test-ing and counseling: increased uptake in two public com-munity health centers in South Africa and implications for scale-up. PLoS ONE 2011; 6(11): e27293.
   PubMed Web of Science ®Google Scholar
• Topp SM, Chipukuma JM, Chiko MM, et al. Opt-out provider-initiated HIV testing and counselling in primary care outpatient clinics in Zambia. Bull World Health Organ. 2011; 89(5): 328–335A.
   PubMed Web of Science ®Google Scholar
• Maher L, Coupland H, Musson R. Scaling up HIV treat-ment, care and support for injecting drug users in Vietnam. Int J Drug Policy. 2007; 18(4): 296–305.
   PubMed Web of Science ®Google Scholar
• Hong K, Nguyen T, Ogden J. “Because this is the disease of the century”: understanding HIV and AIDS-related stigma and discrimination in Vietnam. International Center for Research on Women; 2004.
   Google Scholar
• Rudolph AE, Davis WW, Quan VM, et al. Perceptions of community- and family-level injection drug user (IDU)- and HIV-related stigma, disclosure decisions and experiences with layered stigma among HIV-positive IDUs in Vietnam. AIDS Care. 2011: 1–6.
   Web of Science ®Google Scholar
• Thi M, Brickley DB, Vinh DT, et al. A qualitative study of stigma and discrimination against people living with HIV in Ho Chi Minh City, Vietnam. AIDS Behav. 2008; 12(4 suppl): S63–70.
   PubMed Web of Science ®Google Scholar
• Pharris A, Hoa NP, Tishelman C, et al. Community patterns of stigma towards persons living with HIV: a population-based latent class analysis from rural Vietnam. BMC Public Health. 2011; 11(1): 705.
   PubMed Web of Science ®Google Scholar
• Ministry of Health. Legal Documentation on HIV/AIDS. Hanoi: Ministry of Health; 2004.
   Google Scholar
• Andersen R, Bozzette S, Shapiro M, et al. Access of vul-nerable groups to antiretroviral therapy among persons in care for HIV disease in the United States HCSUS Con-sortium. HIV Cost and Services Utilization Study. Health Service Res. 2000; 35(2): 389–416.
   PubMed Web of Science ®Google Scholar
• Celentano DD, Vlahov D, Cohn S, et al. Self-reported anti-retroviral therapy in injection drug users. J Am Med Assoc. 1998; 280(6): 544–546.
   PubMed Web of Science ®Google Scholar
• Mulissa Z, Jerene D, Lindtjorn B. Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia. PLoS ONE. 2010; 5(10): e13268.
   PubMed Web of Science ®Google Scholar
• Battegay M, Fehr J, Flückiger U, Elzi L. Antiretroviral therapy of late presenters with advanced HIV disease. J Antimicrobial Chemother 2008; 62(1): 41–44.
   PubMed Web of Science ®Google Scholar
• Lawn SD, Harries AD, Wood R. Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings. Curr Opin HIV AIDS. 2010; 5(1): 18–26.
   PubMed Web of Science ®Google Scholar
• Kouanda S, Meda IB, Nikiema L, et al. Determinants and causes of mortality in HIV-infected patients receiving anti-retroviral therapy in Burkina Faso: a five-year retrospective cohort study. AIDS Care. 2011: 1–13.
   Web of Science ®Google Scholar
• Lapadula G, Torti C, Maggiolo F, et al. Predictors of clini-cal progression among HIV-1-positive patients starting HAART with CD4 T-cell counts 200 cells/mm3. Antiviral Ther 2007; 12: 941–947.
   PubMed Web of Science ®Google Scholar
• Ha PN, Pharris A, Huong NT, et al. The evolution of HIV policy in Vietnam: from punitive control measures to a more rights-based approach. Global Health Action. 2010; 3: 10.3402/gha.v3i0.4625.
   Web of Science ®Google Scholar
• Chi BH, Cantrell RA, Mwango A, et al. An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs. Am J Epide-mioL 2010; 171(8):924–931.
   PubMed Web of Science ®Google Scholar
• Larson BA, Brennan A, McNamara L, et al. Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Trop Med Int Health. 2010; 15: 43–47.
   PubMed Web of Science ®Google Scholar
• Latthaphasavang V, Bouldouyre MA, Rachline A, et al. Antiretroviral therapy initiation in France: adherence to national guidelines and outcome. J Int Assoc Physicians AIDS Care. 2012; 11(1): 40–46.
   Google Scholar